Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Status:
Recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
Hypo-Combi Trial: A Prospective Phase I/II Study of Combined Hypofractionated External Beam
Radiation Therapy (EBRT) plus Interstitial High-Dose-Rate Brachytherapy (HDR-BT) for
Intermediate/High Risk Prostate Cancer